- Home
- ARCT vs LDP Comparison
ARCT vs LDP Comparison
Compare ARCT & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- LDP
- Stock Information
- Founded
- ARCT 2013
- LDP 2012
- Country
- ARCT United States
- LDP United States
- Employees
- ARCT N/A
- LDP N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- ARCT Health Care
- LDP Finance
- Exchange
- ARCT Nasdaq
- LDP Nasdaq
- Market Cap
- ARCT 487.0M
- LDP 607.2M
- IPO Year
- ARCT N/A
- LDP N/A
- Fundamental
- Price
- ARCT $17.31
- LDP $20.09
- Analyst Decision
- ARCT Strong Buy
- LDP
- Analyst Count
- ARCT 7
- LDP 0
- Target Price
- ARCT $65.00
- LDP N/A
- AVG Volume (30 Days)
- ARCT 422.7K
- LDP 102.5K
- Earning Date
- ARCT 03-06-2025
- LDP 01-01-0001
- Dividend Yield
- ARCT N/A
- LDP 7.91%
- EPS Growth
- ARCT N/A
- LDP N/A
- EPS
- ARCT N/A
- LDP N/A
- Revenue
- ARCT $160,399,000.00
- LDP N/A
- Revenue This Year
- ARCT $7.33
- LDP N/A
- Revenue Next Year
- ARCT $4.71
- LDP N/A
- P/E Ratio
- ARCT N/A
- LDP N/A
- Revenue Growth
- ARCT N/A
- LDP N/A
- 52 Week Low
- ARCT $14.30
- LDP $16.16
- 52 Week High
- ARCT $45.00
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- ARCT 48.23
- LDP 36.16
- Support Level
- ARCT $16.01
- LDP $20.02
- Resistance Level
- ARCT $21.26
- LDP $20.66
- Average True Range (ATR)
- ARCT 1.37
- LDP 0.22
- MACD
- ARCT 0.21
- LDP -0.01
- Stochastic Oscillator
- ARCT 40.60
- LDP 10.16
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.